Showing results (211-220 of 297) with videos related to
Sort By:
Pageof 30
International Journal of Molecular Sciences|September 9, 2023
The sGC Activator Runcaciguat Has Kidney Protective Effects and Prevents a Decline of Kidney Function in ZSF1 RatsJan R Kraehling, Agnes Benardeau, Tibor Schomber, et al.Kidney International Reports|October 26, 2020
IgA Nephropathy Genetic Risk Score to Estimate the Prevalence of IgA Nephropathy in UK BiobankKittiya Sukcharoen, Seth A Sharp, Nicholas J Thomas, et al.Journal of the American Society of Nephrology : JASN|October 19, 2017
Effects of Two Immunosuppressive Treatment Protocols for IgA NephropathyThomas Rauen, Christina Fitzner, Frank Eitner, et al.Journal of the American Society of Nephrology : JASN|August 26, 2003
A fully human monoclonal antibody (CR002) identifies PDGF-D as a novel mediator of mesangioproliferative glomerulonephritisTammo Ostendorf, Claudia R C van Roeyen, Jeffrey D Peterson, et al.Kidney International|June 7, 2025
Zigakibart demonstrates clinical safety and efficacy in a Phase 1/2 trial of healthy volunteers and patients with IgA nephropathyLaura Kooienga, Jeannette Lo, Eun Young Lee, et al.The New England Journal of Medicine|December 3, 2015
Intensive Supportive Care plus Immunosuppression in IgA NephropathyThomas Rauen, Frank Eitner, Christina Fitzner, et al.Kidney International Reports|July 18, 2025
Erratum to "Using the International IgA Nephropathy Prediction Tool to Enrich Clinical Trial Cohorts" [Kidney International Reports Volume 10, Issue 4, April 2025, Pages 1283-1287]Sean J Barbour, Rosanna Coppo, Jonathan Barratt, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 25, 2020
Macrophage interactions with collecting duct epithelial cells are capable of driving tubulointerstitial inflammation and fibrosis in immunoglobulin A nephropathyIzabella Z A Pawluczyk, Maria S F Soares, William A Barratt, et al.Kidney International|May 29, 2020
Improving treatment decisions using personalized risk assessment from the International IgA Nephropathy Prediction ToolSean J Barbour, Mark Canney, Rosanna Coppo, et al.Journal of the American Society of Nephrology : JASN|February 18, 2017
Galactosylation of IgA1 Is Associated with Common Variation in C1GALT1Daniel P Gale, Karen Molyneux, David Wimbury, et al.Pageof 30